Hillege H - Search Results

1

New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk.

Lu Y, Day FR, Gustafsson S, Buchkovich ML, Na J, Bataille V, Cousminer DL, Dastani Z, Drong AW, Esko T, Evans DM, Falchi M, Feitosa MF, Ferreira T, Hedman ÅK, Haring R, Hysi PG, Iles MM, Justice AE, Kanoni S, Lagou V, Li R, Li X, Locke A, Lu C, Mägi R, Perry JR, Pers TH, Qi Q, Sanna M, Schmidt EM, Scott WR, Shungin D, Teumer A, Vinkhuyzen AA, Walker RW, Westra HJ, Zhang M, Zhang W, Zhao JH, Zhu Z, Afzal U, Ahluwalia TS, Bakker SJ, Bellis C, Bonnefond A, Borodulin K, Buchman AS, Cederholm T, Choh AC, Choi HJ, Curran JE, de Groot LC, De Jager PL, Dhonukshe-Rutten RA, Enneman AW, Eury E, Evans DS, Forsen T, Friedrich N, Fumeron F, Garcia ME, Gärtner S, Han BG, Havulinna AS, Hayward C, Hernandez D, Hillege H, Ittermann T, Kent JW, Kolcic I, Laatikainen T, Lahti J, Mateo Leach I, Lee CG, Lee JY, Liu T, Liu Y, Lobbens S, Loh M, Lyytikäinen LP, Medina-Gomez C, Michaëlsson K, Nalls MA, Nielson CM, Oozageer L, Pascoe L, Paternoster L, Polašek O, Ripatti S, Sarzynski MA, Shin CS, Narančić NS, Spira D, Srikanth P, Steinhagen-Thiessen E, Sung YJ, Swart KM, Taittonen L, Tanaka T, Tikkanen E, van der Velde N, van Schoor NM, Verweij N, Wright AF, Yu L, Zmuda JM, Eklund N, Forrester T, Gra… See abstract for full author list ➔ Lu Y, et al. Among authors: hillege h. Nat Commun. 2016 Feb 1;7:10495. doi: 10.1038/ncomms10495. Nat Commun. 2016. PMID: 26833246 Free PMC article.

2

C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease.

Stuveling EM, Hillege HL, Bakker SJ, Asselbergs FW, de Jong PE, Gans RO, de Zeeuw D; PREVEND study group. Stuveling EM, et al. Atherosclerosis. 2004 Jan;172(1):107-14. doi: 10.1016/s0021-9150(03)00252-1. Atherosclerosis. 2004. PMID: 14709363

3

C-reactive protein modifies the relationship between blood pressure and microalbuminuria.

Stuveling EM, Bakker SJ, Hillege HL, Burgerhof JG, de Jong PE, Gans RO, de Zeeuw D; PREVEND Study Group. Stuveling EM, et al. Hypertension. 2004 Apr;43(4):791-6. doi: 10.1161/01.HYP.0000120125.08867.42. Epub 2004 Feb 16. Hypertension. 2004. PMID: 14967837

4

Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.

Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE. Verhave JC, et al. J Am Soc Nephrol. 2004 May;15(5):1316-22. J Am Soc Nephrol. 2004. PMID: 15100372

5

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.

Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE; PREVEND Study Group. Verhave JC, et al. Kidney Int Suppl. 2004 Nov;(92):S18-21. doi: 10.1111/j.1523-1755.2004.09205.x. Kidney Int Suppl. 2004. PMID: 15485409 Review.

6

Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC.

Brinkman JW, Bakker SJ, Gansevoort RT, Hillege HL, Kema IP, Gans RO, de Jong PE, de Zeeuw D. Brinkman JW, et al. Kidney Int Suppl. 2004 Nov;(92):S69-75. doi: 10.1111/j.1523-1755.2004.09219.x. Kidney Int Suppl. 2004. PMID: 15485424 Free article. Review.

7

The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population.

Gansevoort RT, Verhave JC, Hillege HL, Burgerhof JG, Bakker SJ, de Zeeuw D, de Jong PE; PREVEND Study Group. Gansevoort RT, et al. Kidney Int Suppl. 2005 Apr;(94):S28-35. doi: 10.1111/j.1523-1755.2005.09408.x. Kidney Int Suppl. 2005. PMID: 15752236 Free article. Clinical Trial.

8

The association between atherosclerotic risk factors and renal function in the general population.

Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE; PREVEND Study Group. Verhave JC, et al. Kidney Int. 2005 May;67(5):1967-73. doi: 10.1111/j.1523-1755.2005.00296.x. Kidney Int. 2005. PMID: 15840045 Free article.

9

Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.

Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group. Brantsma AH, et al. Among authors: hillege hl. Diabetes Care. 2005 Oct;28(10):2525-30. doi: 10.2337/diacare.28.10.2525. Diabetes Care. 2005. PMID: 16186291

10

C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort.

Geluk CA, Post WJ, Hillege HL, Tio RA, Tijssen JGP, van Dijk RB, Arnold Dijk W, Bakker SJL, de Jong PE, van Gilst WH, Zijlstra F. Geluk CA, et al. Among authors: hillege hl. Atherosclerosis. 2008 Jan;196(1):372-382. doi: 10.1016/j.atherosclerosis.2006.11.013. Epub 2006 Dec 8. Atherosclerosis. 2008. PMID: 17157301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters